Xuanzhu Biopharmaceutical Co., Ltd. (HKG:2575)
Hong Kong · Delayed Price · Currency is HKD 10.60
-0.13 (-1.21%)
Aug 27, 2026, 3:50 PM HKT
Xuanzhu Biopharmaceutical Market Cap
Xuanzhu Biopharmaceutical has a market cap or net worth of 5.56 billion as of August 26, 2026.
Market Cap
5.56B
Enterprise Value
4.97B
Revenue
119.28M
Ranking
n/a
PE Ratio
n/a
Stock Price
10.60
ChartMarket Cap Chart
Since October 15, 2025, Xuanzhu Biopharmaceutical's market cap has decreased from 13.62B to 5.56B, a decrease of -59.20%. That is a compound annual growth rate of -64.50%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2026 | 5.56B | -84.78% |
| Dec 31, 2025 | 36.52B | 168.06% |
| Oct 15, 2025 | 13.62B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Consun Pharmaceutical Group | 11.24B |
| Shandong Xinhua Pharmaceutical Company | 8.82B |
| Luye Pharma Group | 8.59B |
| Shanghai Fudan-Zhangjiang Bio-Pharmaceutical | 7.77B |
| Sihuan Pharmaceutical Holdings Group | 7.76B |
| SSY Group | 7.27B |
| China Traditional Chinese Medicine Holdings Co. | 6.97B |
| CF PharmTech | 6.24B |